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RIASSUNTO 
 
Introduzione e scopo dello studio: L‟osteoartrosi del ginocchio (KOA) è la maggiore 
causa di disabilità e dolore nella popolazione anziana. L'obesità è considerata il fattore di 
rischio modificabile più comune per l'insorgenza e la progressione della KOA. Sebbene i 
meccanismi che collegano le due patologie sono poco chiari, dati recenti suggeriscono un 
ruolo significativo mediato dal tessuto adiposo infrapatellare (IFP). Lo scopo di questo 
lavoro è quello di descrivere le caratteristiche istomorofologiche dell‟ IFP in soggetti 
affetti da KOA e confrontarle con quelle ottenute da soggetti sani, utilizzando un sistema 
di „score‟ istologico. Inoltre, abbiamo valutato l'espressione dei varie adipocitochine nell‟ 
IFP di soggetti con KOA. 
Materiali e Metodi: Sono stati arruolati 28 soggetti (BMI 35,5 ± 5 kg / m
2
) sottoposti a 
sostituzione totale del ginocchio per KOA. Sono stati utilizzati come controlli, campioni 
di IFP con membrana sinoviale adiacente prelevati da 8 donatori del programma “Donarsi 
alla Scienza” dell‟Istituto di Anatomia Umana presso l'Università di Padova. L'aspetto 
microscopico dell‟ IFP è stato analizzato con metodi istologici e morfometrici. E‟ stato 
anche effettuato l'esame istologico della membrana sinoviale adiacente all‟IFP. Abbiamo 
determinato l'espressione di mRNA utilizzando real time PCR quantitativa per le seguenti 
adipochine (leptina, adiponectina, Peroxisome proliferator-activated receptor gamma, 
Fatty acids binding protein 4) e citochine (interleuchina 6 [IL-6], fattore di necrosi 
tumorale alfa [TNF-α], Monocyte chemoattractant protein-1 [MCP-1], vascular 
endothelial growth factor [VEGF]) nei campioni dell‟IFP dei soggetti affetti da KOA. 
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Risultati:I campioni di IFP hanno evidenziato caratteristiche microscopiche simili al 
tessuto adiposo bianco. L‟IFP è organizzato in lobuli adiposi separati da setti fibrosi. Non 
sono state rilevate differenze nel diametro medio del lobulo adiposo dell‟IFP sia nei 
soggetti affetti da KOA che nei controlli. L‟ infiltrazione Mononucleare  è presente in 22 
soggetti con KOA, mentre non è stata osservata in nessun IFP dei controlli (p = 0.001). Il 
numero medio dei vasi e lo spessore dei setti interlobulari sono significativamente più alti 
nei soggetti con KOA rispetto ai controlli (p <0.0001 e p = 0,004 rispettivamente). Il 
BMI correlava positivamente con lo spessore dei setti interlobulari nell‟ IFP (p = 0.02, r = 
0.42). Inoltre, l‟infiltrazione linfocitaria e l‟iperplasia sinoviale erano più accentuate nel 
KOA rispetto ai controlli (p <0.001 e p = 0.001 rispettivamente). La membrana sinoviale 
era anche più vascolarizzata e fibrotica rispetto ai controlli (p <0.001 e p = 0.002 
rispettivamente).Per quanto riguarda l‟analisi molecolari, l‟ IFP mostrava un espressione 
dei geni tipiche del tessuto adiposo infiammato come IL-6, TNF-α, MCP-1 e VEGF. 
Inoltre, abbiamo osservato una correlazione positiva tra l‟angiogenesi sinoviale e l‟ 
espressione genica del VEGF nell‟ IFP (p = 0.04). 
Conclusione: Il nostro studio è il primo che descrive le caratteristiche istopatologiche 
dell‟ IFP in soggetti prevalentemente  sovrappeso/obesi affetti da KOA. L‟IFP aveva un 
fenotipo patologico caratterizzato dall‟alterazione a livello della dimensione del lobulo, 
dello spessore dei setti interlobulari,  del grado di vascolarizzazione ed dell‟infiltrato 
infiammatorio. Queste alterazioni strutturali sono state associate ad un‟infiammazione a 
livello della membrana sinoviale adiacente. Inoltre, abbiamo aggiunto un‟altra prova 
dell'esistenza di una probabile crosstalk tra citochine prodotte dall‟ IFP e la membrana 
sinoviale. 
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ABSTRACT 
 
Background and aims: Knee osteoarthritis (KOA) is a common cause of disability and 
pain in adults. Obesity is increasingly recognized as the primary modifiable risk factor for 
the onset and progression of KOA. The mechanisms that link the two conditions are still 
not fully clarified but recent data suggest an important role mediated by the infrapatellar 
fat pad (IFP). Accordingly, we aimed to determine the histomorphological characteristics 
of IFP in individuals affected by KOA and compare them to those obtained from lean 
healthy individuals using a histological scoring system. Moreover, we determined the 
expression of certain adipocytokines in IFP of KOA subjects. 
Materials and Methods: We enrolled 28 subjects (BMI 35.5±5 kg/m2) undergoing total 
knee replacement for OA. The controls were represented by IFP and adjacent synovial 
membrane specimens sampled from bodies or bodies part of 8 healthy subjects without 
history of osteoarthritis involved in the Body Donation Program „Donation to Science‟ 
held by the University of Padova. The microscopic anatomy of IFP was analyzed through 
histological and morphometrical methods. The histology of the synovial membrane 
adjacent to the IFP was also analyzed. We determined  mRNA expression using 
Quantitative real time PCR for adipokines (leptin, adiponectin, Peroxisome proliferator-
activated receptor gamm, fatty acid binding protein4) and cytokines (Interleukin 6 [IL-6], 
Tumor necrosis factor alfa[TNF-α], Monocyte chemoattractant protein-1[MCP-1],  
Vascular endothelial growth factor [VEGF]) in the IFP specimens of KOA subjects. 
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Results: All the evaluated IFPs showed microscopical characteristics similar to white 
adipose tissue.  IFPs were organized in adipose lobuli separated by fibrous septa. No 
differences were detected in the mean diameter of the adipose lobuli of the IFP in KOA 
patients and controls. Mononuclear infiltration was present in 22 KOA patients while it 
was not observed in any of the IFP used as control (p = 0.001). The average number of 
vessels and the thickness of interlobular septa were significantly higher in KOA patients 
compared to controls (p < 0.0001 and p = 0.004 respectively). BMI correlated positively 
with the thickness of the interlobular septa in IFP (p= 0.02, r= 0.42). Concerning synovial 
membrane, the presence of lymphocytic infiltration and hyperplasia was statistically 
higher in KOA compared to controls (p <0.001 and p = 0.001 respectively) and it was 
more vascularized and fibrotic compared to controls (p <0.001 and p = 0.002 
respectively). Furthermore, in IFP samples it was noticed an expression of genes typical 
of inflammed adipose tissue such as IL-6, TNF-α, MCP-1 and VEGF. Moreover, we 
observed a positive correlation between the number of blood vessels of KOA synovial 
membrane and mRNA expression of VEGF in IFP (p=0.04). 
Conclusion: Our study describes for the first time the histopathological characteristics of 
IFP in a large cohort of patients with KOA. IFP showed pathologic structural changes in 
the lobule dimension, interlobular septa, vascularization and inflammatory infiltrate. 
These changes were associated with synovial inflammation. Moreover, we added 
evidence about the existence of a probable crosstalk between cytokines produced by IFP 
and the synovial membrane. 
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INTRODUCTION 
 
1. Adipose organ: Insights into the anatomy and physiology 
In mammals the adipose tissues are organized in a multi-depot organ called the „adipose 
organ‟ (1). Although the adipose organ is mainly involved in the store and release of fat 
in response to energy balance needs, it also has immune, endocrine, regenerative, 
mechanical, and thermal functions (2). The adipocytes represent the main parenchymal 
cells of the adipose organ. Traditionally, these adipocytes are divided in two cytotypes, 
white and brown adipocytes, with distinctive anatomical and functional features (1, 3). 
These cells are organized in two tissues, white adipose tissue (WAT) and brown adipose 
tissue (BAT). 
1.1. White and brown adipose tissues 
White adipocyte is a large spherical cell which stores lipids in the form of unilocular 
droplet that occupy about 90% of cell volume and thereby determine the cell size which 
ranges from 10 to over 200 microns in diameter (4, 5). The role of WAT is to store excess 
dietary fat in the form of triglycerides and to release free fatty acids (FFAs) in times of 
starvation or energy demand. WAT is distributed in two anatomical compartments of the 
body: visceral (VAT) and subcutaneous (SAT). VAT surrounds the inner organs and can 
be divided in omental, mesenteric, retroperitoneal (surrounding the kidney), gonadal 
(attached to the uterus and ovaries in females and epididymis and testis in men), and 
pericardial. It has been thoroughly confirmed that the adipocytes of visceral fat tissue are 
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more lipolytically active and thus contribute more to the FFA levels (6, 7). Particularly, 
visceral fat depots, including omental and mesenteric adipose tissue, represent a risk 
factor for the development of cardiovascular disease and type 2 diabetes mellitus. SAT 
store >80% of total body fat in the body. The most commonly defined and studied 
subcutaneous depots are the abdominal, gluteal and femoral (8). 
Brown adipocytes are smaller than white adipocytes, have multilocular fat droplets, a 
high content of mitochondria, and a high level of expression of uncoupling protein 1 
(UCP1) in the inner membrane of mitochondria. UCP1 is a critical player in allowing 
electrons to be released rather than stored, resulting in heat release (9, 10).  
Most brown fat cells originate from precursor cells in the embryonic mesoderm that also 
give rise to skeletal muscle cells and a subpopulation of white adipocytes (11, 12). In 
rodents, BAT is found in the interscapular, perirenal, and periaortic regions. In human 
infants, similar to rodents, BAT depots mainly reside in the interscapular and perirenal 
area and this depot gradually disappears with increasing age (13, 14). Human adults 
mainly have BAT in the cervical, supraclavicular, axillary and paravertebral areas as 
demonstrated by cold-induced 18F-fluorodeoxyglucose (18F-FDG) uptake assessed by 
positron emission tomography scan (PET-CT) (15, 16). It is well established that BAT is 
the major site of nonshivering thermogenesis in human and rodent models (17, 18). In 
1979, Rothwell and Stock first reported that BAT was also activated in rodents when they 
overeat as a mechanism to preserve energy balance and limit weight gain so-called diet-
induced thermogenesis (19). In humans, heat production by BAT, despite its low amount, 
contributes up to 15% of total energy expenditure (20). Given the effect of BAT on  
 
7 
 
 
overall energy balance, today this tissue is increasingly regarded as a novel therapeutical 
target to counteract obesity and associated comorbidities. 
 
1.2. Plasticity of adipose organ 
In the last years it has been extensively studied a novel form of fat cells called beige 
adipocytes (or brite, brown-like, inducible brown). These are defined as 
UCP1‑ expressing, multilocular adipocytes that appear in white (or predominantly white) 
fat depots (21, 22). Clusters of beige adipocytes can develop in WAT in response to 
various stimuli as cold acclimation (young 1984) and chronic treatment with β3-
adrenergic receptor activators (22).  Despite beige and brown share similar thermogenic 
ability they are considered distinct cell types since beige cells, at least those in the mouse 
subcutaneous depot, do not derive from the same embryonic precursors (Myf5 (encoding 
myogenic factor 5)-expressing) that give rise to brown adipocytes (12). The origin of 
beige adipocytes residing in WAT still not fully clarified. Some studies have shown that 
they originate from the trans-differentiation of mature white adipocytes (24, 25) while 
others support the idea that beige adipocytes arise by de novo differentiation from a 
precursor population (26) Taking into account the scarcity of BAT in adult humans, 
WAT to BAT conversion as future treatment for obesity may represent a promising 
strategy to tackle obesity (27) 
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1.3. Adipose organ in obesity 
Obesity is the epidemic of the 21st century. Owing to the modern sedentary lifestyle in 
both developed and rapidly developing countries, the prevalence of obesity has reached 
an alarming level, affecting over 500 million adults and 40 million children (28 Obesity 
is characterized by an abnormal and excess accumulation of adipose tissue in the body. 
Body mass index (BMI) is defined as a person's weight in kilograms divided by the 
square of his height in meters (kg/m2) and it is commonly used to define obesity in 
adults. The World Human Organization defined obesity by BMI greater than or equal to 
30. Obesity is associated with higher mortality and an elevated risk to develop diseases, 
such as type 2 diabetes, cardiovascular disease, musculoskeletal disorders and several 
types of cancer (29,30). With the development of obesity adipose tissue becomes 
dysfunctional, mainly VAT which is responsible of the metabolic complications in 
obesity (31, 32). As individuals become obese, adipose tissue undergoes molecular and 
cellular alterations affecting systemic metabolism. Lipid overload leads to an increase in 
the volume and number of white adipocytes, mainly in visceral depots, that contribute to 
the adipocyte hyperlypolytic state characterized by an in increase in the efflux of free 
fatty acids into circulation with conseguent decrease of insulin sensitivity in skeletal 
muscle, liver and pancreas (33, 34). Moreover, the increased catabolism in mitochondria 
of hypertrophic adipocytes leads to oxidative stress and production of free radicals (35, 
36). This is also associated with an increased endoplasmic reticulum stress due to an 
altered processing of excess of nutrients (37) and subsequently the hypertrophic 
adipocyte becomes dysfunctional and die (38).  
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It is well known that the adipose tissue produces and releases a variety of pro-
inflammatory and anti-inflammatory factors, including the adipokines (proteins produced 
mainly by adipocytes). Most notable between them are leptin, adiponectin, resistin, and 
visfatin, as well as cytokines and chemokines not specific to adipocytes such as tumor 
necrosis factor- α (TNF-α), interleukins (ILs), monocyte chemoattractant protein-1 
(MCP-1) and others that act in an autocrine, paracrine, or endocrine (39).  The distressed 
hypertrophic adipocytes in obese adipose tissue produces abnormal amount of pro-
inflammatory adipokines/cytokines causing recruitment of resident and circulating bone 
marrow-derived monocytes into the tissue (40, 41, 42). The majority of such activated 
adipose tissue macrophages (ATM) surround the dead adipocytes remnants forming 
distinctive figures called crown-like structures (CLS) (38).  These macrophages forming 
the CLS have the main role to sequester and ingest adipocyte debris that is similar to a 
certain extent to those seen in foreign body tissue reaction. Moreover, WAT macrophages 
are subjected to phenotypic polarization in obesity, resulting in an increase in classically 
activated, pro-inflammatory M1 macrophages and reduction in alternatively activated, 
anti-inflammatory M2 macrophages (43).  
Despite ATM are responsible for the major production of pro-inflammatory cytokines in 
obese adipose tissue, several cell types of the immune system and present in the stromal 
vascular fraction (SVF) are also involved as the mast cells, eosinophils, neutrophils and 
natural killer cells (44). Taken together, these phenomena induce a chronic inflammation 
of adipose tissue in obese states. Additionally, the failure of vasculature to expand in 
same proportion of adipocyte volume induces adipose tissue microhypoxia that  
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contributes to the inflammatory process within the tissue (45). The role played by the 
immune system in the inflammatory process of the obese adipose organ is summarized in 
figure 1.  
 
Figure 1. Immune cell trafficking in obesity. (A) In lean adipose tissue, adipocytes store 
triglycerides in a large unilocular droplet in presence of alternatively activated „M2‟ 
macrophages. (B) As obesity progresses and adipose tissue expands, hypertrophy and 
hyperplasia ensues: adipocytes accumulate triglycerides and grow large, while pre-adipocytes are 
differentiated to mature adipocytes. Alterations in adipokines are prognostic: leptin rises and 
adiponectin falls with increasing obesity. Chemokines are released, such as MCP1, which recruit 
monocytes that polarize to pro-inflammatory M1 macrophages (149). 
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1.4. Heterogeneity of adipose depots  
Regional differences exist in adipose tissue morphological and functional characteristics. 
Different fat depots have distinct glycoprotein, adipokine, and paracrine secretion profiles 
and capacities to activate or respond to hormones. Several factors contribute to these 
differences as the „microenvironment‟ and the different cell types present in the fat 
depots, particularly macrophages subtypes which have characteristics that vary among 
organs (46). Here below I‟ll discuss briefly commonly studied local adipose depots that 
had gained an interest in the last years due to their crucial role in the crosstalk with the 
neighboring tissues. 
 
1.4.1. Epicardial fat 
Epicardial adipose tissue (EAT) is one of the local depots of visceral adipose tissue; it is 
situated between the myocardium and the visceral layer of the pericardium (47). EAT has 
a high energy metabolism that prevent large amount of lipid storage (48). Compared with 
other visceral adipose depots, epicardial fat is mainly composed of preadipocytes than 
mature adipocytes, has a great capacity for FFA release and uptake that manily serves as 
an energy source for the myocardium (49 The anatomical location of this pad suggests a 
paracrine or vasocrine crosstalk between the epicardial fat and the underlying 
myocardium and coronary circulation. Infact, human epicardial fat expresses abundant 
levels of UCP1 protein similar to BAT that suggest a thermogenic capacity that might 
serve as a heat provider to the myocardium during a drop of body temperature or during 
certain conditions of hypoxia or ischaemia (50). Moreover, studies have shown that  
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epicardial fat volume was considered as an independent risk factor for coronary artery 
disease (CAD) and therefore regarded as a potential marker of cardiovascular risk (51). 
Under physiological conditions it secretes anti-atherogenic adipokines as adiponectin that 
become downregulated in case of CAD or heart failure (52). Moreover, in patients 
affected by CAD, epicardial fat was highly infiltrated with pro-inflammatory 
macrophages M1 (53) associated with an upregulation and secretion of inflammatory 
cytokines (MCP-1, IL-6, IL-1β, TNF-α) that pass to the adjacent myocardium and 
coronary arteries (54). 
 
1.4.2. Mesenteric fat 
Mesenteric fat had shown to play an important role in the pathogenesis of inflammatory 
bowel disease, particularly Chron‟s Disease (CD). Fat-wrapping, a hall mark of CD, is 
defined as a mesenteric WAT extension from the mesenteric attachment and partially 
covering the small and large intestinal circumference in association with loss of the 
bowel‐mesentery-angle (55). The presence of a correlation between this fat and disease 
characteristics such as ulceration, stricture formation, transmural inflammation, altered 
wall thickness suggested a cross talk between mesenteric adipose tissue and CD (56). In a 
recent study, visceral fat area measured by computed tomography was found to correlate 
with the postoperative recurrence of CD (57). Research suggested that mesenteric adipose 
tissue observed in CD shares some features of those observed in obese states. 
Hypertrophy of the mesenteric WAT has been long recognized as a consistent  
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characteristic of surgical specimens in patients with CD (56). Histopathological 
examination of mesenteric fat obtained from CD patients is characterized by fibrosis, 
perivascular inflammation, intimal and medial thickening of vessels, and significant 
infiltration of inflammatory cells (58). Moreover, overexpression of pro-inflammatory 
adipocytokines as TNF-α and leptin in the mesenteric fat of CD subjects suggested a key 
role of adipose tissue in the intestinal inflammatory process (59, 60). 
 
 
1.4.3. Thymus fat 
The thymus grows rapidly during embryonic life and during childhood, and involutes 
gradually until old age. It has been reported that with increasing age, adipocytes 
constitute the majority of cells in the thymic space, while the number of thymocytes 
substantially decreases (61, 62). Research reports in the last years were interested in the 
angiogenic capacity of human thymus adipose tissue (TAT) (63). TAT obtained from 
adults undergoing cardiac surgery presented an upregulation of angiogenic gene vascular 
endothelial growth factor (VEGF) compared to SAT. In that study, adipogenic genes 
expression as peroxisome proliferator activated receptor-gamma (PPARg) and fatty acid 
binding protein 4 (FABP4) correlated positively with expression of VEGF, which suggest 
a relevant role for these genes in VEGF regulation (64). In a recent study, scientists went 
to evaluate the differentiative capacity of adipose of tissue stromal cells obtained from 
TAT and SAT of patients with myocardial ischemia (65). Compared to SAT, the stromal 
cells deriving from thymic fat showed higher adipogenic differentiative and proliferative  
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capacity that correlated also positively with aging. At the light of these results and in 
presence of a documented angiogenic capacity, TAT was considered a promising tissue 
that can find implication in regenerative medicine aimed to the regeneration of new 
vessels in the ischemic myocardium of elderly subjects. 
 
2. Obesity as a risk factor of knee osteoarthritis 
In the past osteoarthritis (OA) was defined as a degenerative disease mainly related to 
cartilage degradation. New evidence suggests considering OA as a whole joint disease 
(66). According to this, the 2010 EULAR recommendations for diagnosis of knee OA 
(KOA), defined OA as a common joint disorder showing focal cartilage loss, new bone 
formation and involvement of all joint tissues, including menisci, and synovial membrane 
(67).  
Obesity and OA are represent major public health problems in developing and 
industrialized countries that share similarities as the chronic nature, major source of 
disability leading to increased risk of cardiovascular morbidity and mortality (68, 69). 
The knee is considered the main joint affected by OA (70) with a prevalence estimated 
between 10%-13% in people older than 16 years (71). Obesity is reported as the most 
conspicuous risk factor (72, 73) and it is of great interest since it is potentially 
modifiable. Concerning the relationship between obesity and KOA, the Framingham 
study of Felson et al. constituted milestone in this field. By assessing 1420 people for 
KOA, about 33% of study population developed radiographic features of KOA after  
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about 40 years of follow-up. In this large survey the risk of development of KOA was 
related to baseline obesity (74). Today, given the fact that the worldwide prevalence of 
obesity is continuously increasing, interest is growing to understand the link between 
these two conditions which may provide novel targets for the prevention and treatment of 
OA (75). 
2.1. Pathophysiology of obesity and knee joint homeostasis 
There is a debate how obesity contributes to the initiation and progression of KOA. The 
pathogenesis seems to be multifactorial and the candidate mechanisms for the 
contribution of obesity in joint damage include: biomechanical stresses due to increased 
joint loading in presence of a negative metabolic and inflammatory environment caused 
by metabolic risk factors and products of systemic and local adipose tissue.  
 
 
2.1.1 Mechanical stress 
In a recent study, Visser et al. in a cross-sectional cohort including 5002 participants with 
BMI ≥ 27 Kg/m2, supported a prominent role of mechanical stress (weight, fat free mass, 
fat mass) in the pathogenesis of KOA (76). Elevated BMI results in an increased strain on 
medial and lateral parts of the knee (77). In addition, several studies reported that obese 
people have an impaired gait pattern due to kinematic changes, muscle weakness, joint 
misalignment and altered posture which consequently leads to abnormal joint loading 
(78, 79, 80). 
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Increased mechanical stress is associated with bone marrow lesions and thickening of 
cortical subchondral bone possibly through generating an inflammatory phenotype of 
osteoblasts (81). Moreover, activation of mechanoreceptors at surface of chondrocytes by 
compressive stress (82) induces the expression of catabolic phenotype characterized by 
decreased synthesis of the extracellular matrix and increased production of degradative 
matrix metalloproteinases (MMPs), aggrecanase ADAMTS-5 and expression of pro-
inflammatory factors as IL -1β, TNF-α, cyclooxygenase 2 (COX-2) and prostaglandin E2 
(PGE2) (83). There is good evidence that cartilage loss occurs in the same regions of the 
joint as the changes in the subchondral bone, it is thought that there is a crosstalk between 
the stressed subchondral osteoblasts and the overlying chondrocytes (84). 
 
2.1.2. Adipocytokines and systemic inflammation 
Apart from mechanical factors, as mentioned previously, obesity is considered a chronic 
inflammatory disease characterized by the production by adipocytes of cytokines and 
adipokines that may act on different tissues throughout the body. Adipokines, including 
leptin, adiponectin and resistin are most commonly involved in the pathophysiology of 
KOA. Leptin being primarily secreted by adipocytes is known to be an important 
mediator of obesity and OA. First reports on animal models have shown that this peptide 
can mediate anabolic actions on chondrocytes by inducing mRNA and protein expression 
of insulin-like growth factor -1 (IGF-1) and transforming growth factor β (TGF-β) (85). 
Further studies have shown contradictory results when intra-articular injection of leptin in  
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rats resulted in an increased mRNA and protein expression of the following catabolic 
factors: as MMP-2, MMP-9, ADAMTS-4/5, cathepsin, and type II collagen (86). 
Vuolteenaho et al. reported that leptin can enhance nitric oxide (NO), PGE2, IL-6, IL-8 
production in OA human cartilage (87). 
On human OA synovial fibroblast, leptin stimulated the expression of IL-6 and IL-8 (88, 
89). Regarding subchondral osteoblasts leptin is involved in altering the secretion of 
alkaline phosphatase, TGF-β, osteocalcin and collagen type I by these cells and 
subsequently modifying their normal phenotype (90). 
The role of adiponectin in OA pathogenesis has not been completely elucidated. After the 
first report that regarded this peptide as protective factor in OA (91), several studies have 
suggested an opposite role. Recently, adiponectin plasma levels have been found to 
positively correlate with clinical and radiological disease severity of KOA (92). This 
peptide has been detected in both synovial fluid and plasma of OA patients (93) and has 
demonstrated a pro-inflammatory role by inducing the production of MMPs, IL-6, and 
PGE2 by chondrocytes and synovial fibroblasts (94). 
Resistin is a dimeric protein produced by adipocytes and macrophages and it has been 
reported that its levels correlate positively with obesity, insulin resistance and 
inflammatory processes (95). Resistin may play an important role in initiating and 
promoting the development of OA and thus it may represent an important links between 
obesity related metabolic disorders and cartilage destruction (96). Injection of resistin 
into mice joints induces an arthritis-like condition characterized by leukocyte infiltration  
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of synovial tissues, hypertrophy of the synovial layer and pannus formation (97). In a 
recent meta-analysis, resistin expression in blood and synovial fluid was higher in OA 
subjects compared to controls and its level was related to disease prognosis (98). 
 
2.2. Obesity-related metabolic disorders  
It is well established that obesity is usually associated with metabolic disorders as insulin 
resistance, dyslipidemia and hypertension that tend to cluster into the so-called metabolic 
syndrome. These factors have demonstrated to induce a strong cumulative effect on early 
or end-stage KOA incidence (99, 100). The mechanisms by which these factors may alter 
normal knee joint homeoastasis will be discussed separately in the following paragraph. 
(Figure 2) 
2.2.1. Altered glucose metabolism 
In the last years large interest is growing to define the relationship between OA and 
hyperglycemia and/or impaired glucose tolerance (IGT). Both Engstrom et al. and 
Hussain et al. showed an increased KOA risk in patients with hyperglycemia and IGT 
respectively (101, 100). 
The relationship between diabetes and radiographic KOA progression was demonstrated 
in SEKOIA trial by Eymard et al. where type 2 diabetes in men was independently 
associated with greater annualized rates of joint space narrowing (102). 
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Few studies have tried to clarify the link between high blood glucose levels and KOA. In 
osteoarthritic chondrocytes high extracellular glucose concentration has shown to impair 
the downregulation of glucose transporter 1 (GLUT-1) and thus mediating cartilage 
destruction through the high production of reactive oxygen species (ROS) (103). In 
addition high extracellular glucose levels stimulated in osteoarthritic chondrocytes the 
expression of MMP-1 and MMP-13 (104). Locally the accumulation advanced glycation 
end-products (AGEs) resulted in an increased stiffness of collagen network (105) and in 
activation of the receptor of advanced glycation end products (RAGE) inducing the 
expression of pro-inflammatory mediators as COX-2, PGE2, IL-6, IL-8, TNF-α and 
MMPs (106, 107, 108). Finally, diabetic peripheral neuropathy may represent an 
important risk factor for KOA due to altered proprioceptive acuity and decreased muscle 
strength (109). 
2.2.2. Altered lipid metabolism 
The involvement of altered lipid metabolism in the pathogenesis of OA was proposed by 
several studies. A characteristic of metabolic syndrome is the increased release of FFA 
from adipose tissue caused by impaired inhibition of intracellular lipolysis. High levels of 
FFA are found in joint tissues in OA (110). FFA can aggravate joint inflammation by 
inducing pro-inflammatory response in macrophages activating Toll-like receptors 
(TLRs-2/4) (111). 
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Furthermore, epidemiological studies have demonstrated that high density lipoprotein 
(HDL)-c is decreased in the serum of OA patients compared to non-OA individuals (112, 
113). 
Another fundamental feature of OA pathology is mediated by low density lipoprotein 
(LDL) and its oxidized form (Ox-LDL). Comparative analysis demonstrated that OA 
patients have higher serum LDL compared with age-, sex-, and BMI- matched healthy 
controls (114, 115). Synovial macrophages stimulated by Ox-LDL produced pro-
inflammatory mediators as IL-6, IL-8, MCP-1 and growth factors as TGF-β (116). 
 
2.2.3. Arterial hypertension 
Hypertension, another common feature among morbidly obese population, has 
demonstrated to be an independent risk factor in the pathogenesis of KOA (100). This 
relation was related to vascular pathology since hypertension was proposed to reduce 
blood flow to subchondral bone and consequently impair nutrition and gas supply to the 
overlying cartilage and thus its degeneration (117). In addition, ischemic subchondral 
plate and due to bone loss might be susceptible for microcrack or micro-fracture at 
osteochondral junction under repetitive mechanical loading which contribute to the 
deterioration of cartilage degeneration (118). 
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Figure 2. Multifactorial association between obesity and knee OA. 
The mechanisms responsible for this link are thought to involve mechanical loading, hypertension, 
altered glucose and lipid metabolism. In addition increased visceral adiposity is responsible for a low-
grade systemic inflammation state via the release of inflammatory adipocytokines. These stresses 
together with the pro-inflammatory role mediated by infrapatellar fat pad, which is intimately connected 
to the synovial membrane and presumably there is a cross-talk between it and the other tissue of the 
joint, result in local inflammation and production of catabolic enzymes in joint tissues and subsequently 
promoting articular damage. 
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3. Knee osteoarthritis: a focus on infrapatellar fat pad 
The infrapatellar fat pad (IFP) or Hoffa fat pad of knee joint was firstly described by the 
german surgeon Albert Hoffa in 1904 (119). It is located under the patellar tendon filling 
the space between the patellar tendon, femoral condyles and tibial plateau. It is attached 
to the lower border of the inner non-articular surface of the patella, to the notch between 
the two condyles of the femur by running continuously with the infrapatellar plica 
posterosuperiorly, and to the periosteum of the tibia and the anterior part of the menisci. 
Moreover, this pad is intracapsular but extrasynovial, with synovial lining covering its 
posterior surface (120, 121).  
The periphery of the IFP itself being described as highly vascularized is supplied by 
branches of the superior and inferior genicular artery while more centrally the vascular 
network become more limited (122). 
 From the microscopic point of view, IFP consists of white adipose tissue organized in 
lobuli that are delimited by thin connective septae. The IFP adipocytes are distributed 
with a large intercellular and covered by a thick fibrillary sheaths (123). 
The exact role of IFP is still debated. For years knee fat pad has been thought to have 
mainly biomechanical functions filling the space between joint structures, adapting 
during the knee movement and contributing to the load bearing. In fact, seen its structural 
characteristics IFP could act as a plastic portion aimed at absorption of pressure variation 
during knee articular activity. Moreover, IFP is supposed to supply the blood to the  
23 
 
 
patella tendon and to be involved in the mechanisms inducing pain in KOA (124, 125, 
126). 
Recent evidences suggest that IFP might have not only a biomechanical but also a 
biochemical role in the pathogenesis of diseases such as OA through the secretion of 
inflammatory markers as cytokines and adipokines. The IFP is the main articular adipose 
tissue within the knee. Like all adipose depots, it is an endocrine organ that has shown to 
play a role the pathophysiology of KOA through the secretion of inflammatory mediators 
directly into knee joint. The first report about the inflammatory phenotype of IFP back 
2003 when Ushiyama and colleagues showed in human OA IFP significant protein levels 
of IL-6, TNF-α, VEGF, and basic fibroblast growth factor (b FGF). Additionally, these 
inflammatory cytokines were also detected in the synovial fluid of the same subjects 
(127). When the SAT and IFP of the same subject were compared, IFP expressed higher 
levels of inflammatory cytokines as IL-6, sIL-6R, TNF-α, adipsin, visfatin and 
adiponectin (128, 129). Concerning, the role of excess of weight on the secretory profile 
of IFP, only TNF-α was found to correlate positively with BMI (128). It was 
hypothesized that these differences maybe also influenced by the presence of 
inflammatory cells in the IFP stromal fraction, in particular by the abundant number of 
pro-inflammatory macrophages (128). Moreover, in OA subjects it was demonstrated that 
the culture media of IFP adipocytes induced MMP-1 and MMP-13 expression in articular 
chondrocytes and leptin level correlated positively with the expression of both MMPs and 
cartilage collagen destruction (130). Concerning the synovial membrane, investigators 
have shown that IFP compared to SAT of subjects affected by KOA is able to induce a  
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stronger inflammatory response in the synovial membrane characterized by an increase in 
the levels of inflammatory markers in fibroblast-like synoviocytes (131). The 
contribution of IFP in KOA is summarized in figures 2 and 3. 
 
Figure 3. In the left part of the cartoon the classical OA features are showed: joint space narrowing, cartilage 
degradation, synovial membrane inflammation and hyperplasia, meniscus degeneration and osteophytes 
formation. Here, the role of IFP in OA as a source of cytokines and adipokines participating in the 
inflammatory process of the joint is highlighted. IFP structural changes are shown at cellular and histological 
levels in OA condition compare tothe normality. In healthy individuals IFP showed no lymphocytic infiltration 
and absence of fibrosis as demonstrated by the histology picture (haematoxylin-eosin staining, taken from a 
subject involved in the Body Donation Program „Donation to Science‟ of the held by the University of Padova 
without history of osteoarthritis)(123). On the contrary, the microscopic image (haematoxylin-eosin) of IFP of 
an OA patient undergoing total knee replacement showed lymphocytic infiltration and fibrosis. 
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AIMS OF THE STUDY 
 
 Describe the histomorphological characteristics of infrapatellar fat pad and synovial 
membrane in mainly overweight/obese individuals and affected by knee osteoarthritis. 
 Apply a „scoring‟ system on the histopathologic features of infrapatellar fat pad. 
 Determine the expression of different adipocytokines in infrapatellar fat pad of 
individuals with knee osteoarthritis and possible correlations with microscopic 
parameters of joint tissues. 
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MATERIALS AND METHODS 
 
1. Patients and tissue collection 
28 patients undergoing total knee replacement (TKR) for OA at both Orthopaedic Unit 
and Clinic of Padova University Hospital were enrolled in the study after providing 
written informed consent. The Local Ethical Committee approved the study protocol. For 
each patient the following clinical data were collected: age, sex, body max index (BMI), 
and comorbidities. During the surgical procedure IFP together with adjacent synovial 
membrane were collected and processed as following: a part was fixed in 10% formalin 
and then paraffin-embedded for histochemical and immunohistochemical studies, and a 
part was frozen in liquid nitrogen and conserved at -80 °C for bio-molecular analysis.  
The controls were represented by IFP and adjacent synovial membrane specimens 
sampled from bodies or bodies part of healthy subjects without history of osteoarthritis 
involved in the Body Donation Program „Donation to Science‟ held by the University of 
Padova (123). 
2. Microscopical study 
Thick sections of 10 μm were obtained from the paraffin embedded samples, and were 
stained with haematoxylin-eosin (EE), Azan-Mallory, and Weigert-Van-Gieson stains.  
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The analysis of the samples was focused on the evaluation of both IFP and IFP adjacent 
synovial membrane. The microscopical characteristics of the IFP were scored according 
to the following parameters: presence of inflammatory cells, vascularity, adipose lobuli 
dimension and thickness of the interlobular septa. The presence of inflammatory cells 
was graded as follows: 0 = no presence of mononuclear cell infiltration; 1 = presence of 
perivascular mononuclear cell infiltration; 2 = perivascular and interstitial mononuclear 
cell infiltration. The vascularity was evaluated counting the number of vessels in 4 
sections for each case independently from their diameter. The adipose lobuli dimension 
and the thickness of the interlobular septa were evaluated by morphometry. 
IFP immunohistochemical stains were performed with anti-CD3 antibody (polyclonal 
rabbit antibody, Fitzgerald) to identify the presence of T-cells with a dilution of 1:500. 
The sections were incubated using the DAKO Autostainer System (EnVision™ FLEX, 
High pH). The EnVision™ FLEX reagents are intended for use on formalin-fixed, 
paraffin-embedded tissue section. Sections incubated without primary antibodies showed 
no immunoreactivity, confirming the specificity of the immunostaining.  
The synovial membrane involvement was evaluated according to a synovial 
histopathological grading (132, 133) considering the following parameters: lymphocytic 
infiltration (0-3), synovial hyperplasia (0-2), vascularity (0-2), fibrosis (0-2), mucoid 
change (0-4), and presence of fragments of bone and cartilage (0-2). The grading 
characteristics were scored by an expert pathologist. All sections were observed under a 
DM4500-B light microscope (Leica Microsystems, Wetzlar, Germany) and recorded in 
full colour (24 bit) with a digital camera (DFC 480, Leica Microsystems). 
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3. Morphometry 
After digitizing the images acquired from EE stained sections, the diameter of the 
adipocyte lobuli and the thickness of the interlobular septa were measured, using specific 
imaging software (Adobe Photoshop CS5, Adobe Systems Incorporated, USA). On the 
images acquired at 1.25 X primary magnification the septa were first manually identified. 
Subsequently, with a specific Programming Language Software (Matlab R2012b, The 
MathWorks, Inc., USA) the images were converted to 8-bit binary images. The thickness 
of interlobular septa and the dimension of adipose lobuli were then evaluated. 
4. Quantitative real-time PCR 
Total RNA was extracted from IFP using QIAMP mini kit (QIAGEN) following the 
manufacturer‟s protocol. First-strand cDNAs were synthetized from equal amounts of 
total RNA using random primers and M-MLV reverse trascriptase (Promega). 
Quantitative real time PCR (qRT-PCR) for adipokines (leptin, adiponectin, PPARg, 
FABP4), cytokines (IL-6, TNF-α, MCP-1 and VEGF) was performed using Sybr Green 
fluorofore. The changes in fluorescence at every cycle were monitored and a threshold 
cycle above background for each reaction was calculated. A melting curve analysis was 
performed to ensure a single amplified product for every reaction. All reactions were 
carried out in duplicate for each sample. 18S rRNA was constantly expressed under all 
experimental conditions and was then used as a reference gene for normalization. It was 
not possible to extract mRNA from IFP of cadavers. Primer sequences are listed in table 
(1). 
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Table 1. Primer sets used for quantitative real-time PCR (F= forward, R= Reverse) 
 
TNF-α F:TGCTTGTTCCTCAGCCTCTT 
R:GGGCTACACGCTTGTCA 
IL-6 F:TTCGGTACATCCTCGACG 
R:AAGCATCCATCTTTTTCAGC 
MCP-1 F:CCCCAGTCACCTGCTGTTAT 
R:TGGAATCCTGAACCCACTTC 
PPARg2 F:ACCCAGAAAGCGATTCCTTCA 
R:AGTGGTCTTCCATTACGGAGAGATC 
Leptin  F:GTGCGGATTCTTGTGGCTTT 
 R:GGAATGAAGTCCAAACCGGTG 
Adiponectin F: CCTGGTGAGAAGGGTGAGAA 
R: CAATCCCACACTGAATGCTG 
FABP-4 F: GAAGTCAAGAGCACCATAACC  
R: CCACCACCAGTTTATCATCC 
VEGF F : TCACCARGCAGATTATGCGGA                                 
R: TGTTGTGCTGTAGGAAGCTCA 
18 S F: CTTGTCCCACCACTTGAAGG 
R:CACAGTCATTGCTCAGATCCA 
 
 
5. Statistical analysis 
Inter- and intra-reader reliability of histopathology scores were reported as a weighted 
kappa statistic. Shapiro-Wilk test was used to determine whether data were distributed 
normally.  The data were shown as means ± standard deviations (SD). Chi-square (χ2) 
test or Fisher's exact test were performed to compare categorical and dichotomous data. 
Mann-Whitney test or Student's t-test were used to compare continuous variables. 
Spearman‟s or Pearson‟s correlations were performed to analyse associations between 
continues variables. One-way ANOVA or Kruskal-Wallis, with Tukey‟s post-hoc tests, 
were used to analyse categorical data. A p<0.05 was considered significant. All analyses 
were performed with SPSS version 22.0. 
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RESULTS 
1. Patients demographic and clinical characteristics   
28 patients undergoing TKR were enrolled in the study. Specimens were collected from 8 
cadavers as controls. The demographic and clinical data of OA and control subjects are 
outlighted in Table 2. Females were 75% in the OA group, while 50% in the control 
group (p = 0.047). OA subjects were statistically younger (p < 0.0001) than controls 
(mean age ± SD 68.9 ± 7.8 vs. 81.8 ± 4.9 years). BMI was statistically higher (p = 
0.0002) in OA patients than controls (mean BMI ± SD 30.5 ± 5.0 vs. 21.8 ± 2.3 Kg/m² 
respectively). Moreover, we aimed to assess possible relationship between the 
demographic data of OA patients and the correspondent inflammatory markers and 
histological features.  
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Table 2. Demographic and clinical data of OA patients and controls. * P < 0.05 
 
 OA PATIENTS 
 
CONTROLS P 
Number of patients  
 
28 8  
Sex (female), number (%) 21 (75) 4 (50) 0.047* 
Age, mean (SD), years 68.9 (7.8) 81.8 (4.9) <0.0001* 
*BMI, mean (SD), Kg/m² 30.5 (5.0) 21.8 (2.3) 0.0002* 
Comorbidities  
Hypertension, number (%) 
Diabetes, number (%) 
Hypercholesterolemia, number (%) 
 
17 (68%) 
3 (12%) 
8 (32%) 
6 (60%) 
3 (30%) 
3 (30%) 
 
0.382 
0.073 
0.468 
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2. IFP histology and morphometry  
Twenty seven IFP samples underwent histologic and morphologic analysis (1 sample was 
not analysed for technical reasons). All the evaluated IFPs showed microscopical 
characteristics similar to white adipose tissue.  IFPs were organized in adipose lobuli 
separated by fibrous septa. The IFP histological characteristics are summarized in Table 3 
and figure 4. No differences were detected in the mean diameter of the adipose lobuli of 
the IFP in OA patients and controls.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
33 
 
 
Table 3. IFP histolopathologic scoring system. * P < 0.05 
Hoffa histopathologic grading   OA patients 
(n =27) 
Control 
(n =8) 
P 
Lymphocytic Infiltration, number (%)  
Grade 0 
Grade 1 
Grade 2 
 
5 (18.5%) 
8 (29.6%) 
14 (51.9%) 
 
 
8 (100%) 
0 (0%) 
0 (0%) 
 
0.001* 
Vascularity, mean (SD), number  34.91 (16.26) 11.81 (4.25) <0.0001* 
Thickness of the interlobular septa, mean (SD), mm 0.30 (0.08) 0.23 (0.03) 0.004 * 
Diameter adipose lobuli, mean (SD) 1.09 (0.42) 1.15 (0.11) 0.141 
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Figure 4. Microscopic appearance of the IFP in osteoarthritis (left column) and in control (right 
column), showing the adipose lobuli separated by thick fibrous septa in osteoarthritis (OA) (A) 
with respect of controls (B). In OA patients the vessels were more numerous (C) with respect of 
controls (D) and showed major mononuclear infiltration (E) with respect of controls (f). A-D, 
haematoxylin-eosin; E-F, immune-histochemistry for CD3. Scale bars: (A-D), 600 μm; (E-
F),150 μm. 
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Mononuclear infiltration was present in 22 OA patients while it was not observed in any 
of the IFP used as control (p = 0.001). The average number of vessels and the thickness 
of interlobular septa were significantly higher in OA patients compared to controls (p < 
0.0001 and p = 0.004 respectively). Notably, BMI correlated positively with the thickness 
of the interlobular septa in IFP (p= 0.02, r= 0.42 ). (Figure 5.)  
 
 
Figure 5. Correlation between BMI and thickness of interlobular septa in IFP of KOA subjects 
 
 
 
 
3. Synovial membrane histopathological characteristics 
Since the IFP adjacent synovial membrane was not present in 5 patients, the synovial 
membrane involvement was evaluated in 22 cases.  
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The presence of lymphocytic infiltration and hyperplasia was statistically higher in OA 
synovial membrane compared to controls (p <0.001 and p = 0.001 respectively). In 
addition, synovial membrane of OA patients was more vascularized and fibrotic 
compared to controls (p <0.001 and p = 0.002 respectively). No differences were found in 
mucoid change and detritus between OA patients and controls. The histological 
characteristics of IFP adjacent synovial membrane are described in Table 4 and figure 6. 
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Table 4. Synovitis score of synovial membrane adjacent to IFP. Data are expressed as number 
(%). * P < 0.05 
Sinovitis histopathologic grading   OA patients 
(n =22) 
Control 
(n =8) 
 
P 
Lymphocytic Infiltration (0-3) 
Grade 0 
Grade 1 
Grade 2 
Grade 3  
 
 
 
0 (0%) 
5 (22.7%) 
6 (27.3%) 
11 (50%) 
 
6 (75%) 
2 (25%) 
0 (0%) 
0 (0%) 
<0.001* 
Vascularity (0-2) 
Grade 0 
Grade 1 
Grade 2 
 
 
 
0 (0%) 
6 (27.3%) 
16 (72.7%) 
 
8 (100%) 
0 (0%) 
0 (0%) 
 
<0.001* 
Detritus (0-2) 
Grade 0 
Grade 1 
Grade 2 
 
 
 
19 (86.4%) 
2 (9.1%) 
1 (4.5%) 
 
8 (100%) 
0 (0%) 
0 (0%) 
 
0.545 
Fibrosis (0-2) 
Grade 0 
Grade 1 
Grade 2 
 
 
 
4 (18.2%) 
10 (45.5%) 
8 (36.4%) 
 
7 (87.5%) 
1 (12.5 %) 
0 (0%) 
 
0.002* 
Hyperplasia (0-2) 
Grade 0 
Grade 1 
Grade 2 
 
 
 
3 (13.6%) 
10 (45.5%) 
9 (40.9%) 
 
7 (87.5%) 
1 (12.5%) 
0 (0%) 
 
0.001* 
Mucoid change (0-4) 
Grade 0 
Grade 1 
Grade 2 
Grade 3 
Grade 4 
 
 
16 (72.7%) 
0 (0%) 
3 (13.6%) 
1 (4.5%) 
2 (9.1%) 
 
7 (87.5%) 
1 (12.5%) 
0 (0%) 
0 (0%) 
0 (0%) 
 
0.277 
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Figure 6. Microscopic appearance of the adjacent synovial membrane in osteoarthritis (first raw) 
and in control (second raw), showing the presence of lymphocytic infiltration and hyperplasia of 
the synovial membrane (A and B) with respect of the control (C-D). In OA patients the vessels 
were more numerous (b). A-D, haematoxylin-eosin; scale bars: (A-C), 600 μm; (B-D),150 μm 
 
4. Correlations between gene expression and histological data  
All the analyzed IFP samples from OA patients showed an expression of typical genes of white 
adipose tissue as well as leptin, adiponectin, PPARg, FABP4. Furthermore it was noticed an 
expression of genes typical of inflammed adipose tissue such as IL-6, TNF-α, MCP-1, in 
addition to VEGF (Figure 6.a).  
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We observed a positive correlation between the number of blood vessels of osteoarthritic 
synovial membrane and mRNA expression of VEGF in IFP (p=0.04) (figure 6.b) 
 
  
Figure 6. Relative gene expression is shown (a). While (b) shows the relationship between 
VEGF expression in IFP and grade of synovial hyperplasia in subjects with KOA. 
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DISCUSSION AND CONCLUSION 
 
For many years the association linking obesity to osteoarthritis was attributed entirely for 
the increase of mechanical load. However, it is difficult to explain how BMI is associated 
with in increased risk of OA in non weight-bearing joints as the case of hand 
osteoarthritis (134). Moreover, in the Rotterdam cohort, a high BMI was associated with 
increased incidence and progression of OA of the knee but not of the hip (135). These 
findings suggest a role of additional factor that adds to the effect of mechanical stress and 
systemic low grade inflammation in overweight/obese subjects. In the case of knee the 
responsible factor may be IFP. 
The function of the IFP is still debated, but it is thought to have both biomechanical and 
biological functions (125). Although its removal during total knee arthroplasty remains a 
matter of surgeon preference, recent study has suggested that its preservation is 
associated with improved outcome (136). In our study the IFP of subjects with OA 
showed pathological changes with presence of fibrosis, neoangiogenesis and 
inflammatory infiltration. In particular, IFP showed a statistically significant increase of 
the thickness of interlobular septa and a decrease of the adipose lobuli diameter compared 
to controls. Moreover, thickness of interlobular septa correlated positively with BMI of 
OA patients. In fact, as demonstrated by others, fibrosis was found in the IFP of subjects 
who underwent total knee arthroplasty and resection of a severely fibrotic IFP was 
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recommended since favourable effect has been reported following the surgical procedure 
(137).  
On the other hand, adipose tissue fibrosis was also reported in obesity being associated 
with metabolic complications. Adipose tissue hypoxia initiates fibrosis which is further 
aggravated by chronic inflammation (138). Moreover, the presence of an inflammation 
stimulus in white adipose tissue may be responsible for an excessive synthesis of 
extracellular matrix components and subsequent interstitial deposition of fibrotic 
material. Henegar et al (2008) demonstrated that in white adipose tissue of obese subjects 
there is an increased expression of genes encoding extracellular matrix components 
together with an increased extracellular matrix (139). Fibrosis may represent an 
ubiquitous tissue response to an unresolved chronic inflammation (140). In the present 
study mononuclear infiltration was found in IFP of 81.5 % of OA patients, with 
perivascular and interstitial localization. This data partially agree with those reported by 
Maculè et al. (2005) that found chronic inflammatory infiltration of IFP in 35% of 
patients who underwent total knee arthroplasty (137). Jedrzejczyk et al. (1996) described 
the presence of subsynovial lymphocytic infiltration in IFP of normal subjects, especially 
in older persons (141). In the monoiodoacetate model of OA pain, histopathologic 
features of IFP similar to those observed in our OA study population were reported. 
These alterations included intercellular separation of adipocytes by fibrous tissue 
associated with hyperplastic synovial membrane (142). On the other hand, fibrosis has 
been reported also in other fat pads such as plantar fat pad (143). It has been 
hypothesized that these changes modify the ability of IFP to absorb physiological as well 
as pathological forces acting on knee joint and thus promoting and perpetuating joint  
42 
 
 
damage (142). Further studies could be addressed to define biomechanical models for the 
interpretation of the functional behaviour of IFP. In particular numerical models could be 
able to correlate healthy and degenerative conditions (144). 
Moreover, when assessing the link between the inflammatory profile of IFP and its 
microscopic features of IFP itself or that of synovial membrane; we observed a positive 
correlation between VEGF expression in IFP and the vascularity score of synovial 
membrane. IFP in its anatomic proximity to synovial membrane and by releasing 
inflammatory cytokines has shown to be involved in the induction OA synovitis 
(131).VEGF is a potent angiogenic cytokine that has shown to play a role in OA (145, 
146). This cytokine can also be produced by hypotrophic chondrocytes, macrophages and 
synovial fibroblasts (146, 147). The role of the synovium in OA pathology is becoming 
more evident. In conjunction with cartilage damage and bone alterations, the pathologic 
features of inflammation, hyperplasia, and extensive fibrosis are also often observed in 
the synovium of OA joints (148). These abnormalities although more pronounced in 
advanced OA, are present from the earliest stages of the OA process. 
 
In conclusion, our study describes for the first time the histopathological characteristics 
of IFP in a large cohort of patients with KOA. IFP showed pathologic structural changes 
in the lobule dimension, interlobular septa, vascularization and inflammatory infiltrate. 
These changes were associated with synovial inflammation. Moreover, we added  
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evidence about the existence of a probable crosstalk between cytokines produced by IFP 
and the synovial membrane.  
Our KOA subjects consisted mainly of overweight/obese subjects, thus we cannot 
exclude a possible effect of systemic factors or inflammatory markers on the IFP or 
synovial microscopic phenotype. Even if it seems challenging, further work should 
consider the metabolic inflammation which is a hall mark in obesity and the 
biomechanical aspect when assessing the role of IFP. 
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